AlphaValue/Baader Europe on Friday lowered its rating on biopharmaceutical group Sartorius Stedim Biotech (DIM.PA) to add from buy, while increasing its price target to 222 euros from 220 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)